Literature DB >> 24045966

Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy.

Yuuki Takamura1, Akira Miyauchi, Tomonori Yabuta, Minoru Kihara, Yasuhiro Ito, Akihiro Miya.   

Abstract

BACKGROUND: Increased bone mineral density (BMD) has been reported in patients with postsurgical permanent hypoparathyroidism. Hypoparathyroidism may attenuate the high-turnover bone loss in postmenopausal women. We reported previously that patients who had transient hypoparathyroidism postoperatively were at subclinical hypoparathyroid (hP) status even 5 years after surgery. We hypothesized that patients with transient hypoparathyroidism (ThP) may have altered BMD.
METHODS: A total of 140 women who underwent total thyroidectomy had BMD measurements of the lumbar spine, femoral neck, and radius 3 years after surgery. At surgery, 99 patients were ≥50 years and 41 were <50 years. They were divided into three groups according to their postoperative parathyroid function: There were 80 patients in the no hP (NhP) group, 54 in the ThP group, and 6 in the permanent hP (PhP) group.
RESULTS: Among the 99 patients aged ≥50 years, 36 ThP patients had median Z scores of the BMD in all three areas (lumbar spine, femoral neck, radius) that were significantly higher (by 1.083, 0.533, and 1.047, respectively) than those in the 60 NhP patients aged ≥50 years. The BMDs in the three PhP patients ≥50 years were higher than those in the NhP and ThP patients, but the difference did not reach significance except for in the femoral neck. Multivariate logistic regression analyses showed that Z scores > 0 were significantly associated only with the presence of ThP postoperatively. In the patients <50 years, the BMD values were not significantly different among the three groups except at the radius in PhP patients, which was significantly lower than those of the other patients.
CONCLUSIONS: We found that ThP was associated with increased BMD in postmenopausal women. This may be due to attenuation of the high-turnover bone loss in postmenopausal women.

Entities:  

Mesh:

Year:  2013        PMID: 24045966     DOI: 10.1007/s00268-013-2207-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Bone loss in relation to menopause: a prospective study during 16 years.

Authors:  H G Ahlborg; O Johnell; B E Nilsson; S Jeppsson; G Rannevik; M K Karlsson
Journal:  Bone       Date:  2001-03       Impact factor: 4.398

2.  Parathyroid activity and postmenopausal osteoporosis.

Authors:  M Hossain; D A Smith; B E Nordin
Journal:  Lancet       Date:  1970-04-18       Impact factor: 79.321

3.  Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.

Authors:  L S Richelson; H W Wahner; L J Melton; B L Riggs
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

4.  Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.

Authors:  Rita Schneider; Mara Schneider; Christoph Reiners; Peter Schneider
Journal:  J Clin Endocrinol Metab       Date:  2012-09-13       Impact factor: 5.958

5.  Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.

Authors:  Iwao Sugitani; Yoshihide Fujimoto
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

6.  [Age at natural menopause in Japanese women].

Authors:  T Tamada; H Iwasaki
Journal:  Nihon Sanka Fujinka Gakkai Zasshi       Date:  1995-09

7.  Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.

Authors:  K Fujiyama; T Kiriyama; M Ito; K Nakata; S Yamashita; N Yokoyama; S Nagataki
Journal:  J Clin Endocrinol Metab       Date:  1995-07       Impact factor: 5.958

8.  Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.

Authors:  D S Cooper; B Specker; M Ho; M Sperling; P W Ladenson; D S Ross; K B Ain; S T Bigos; J D Brierley; B R Haugen; I Klein; J Robbins; S I Sherman; T Taylor; H R Maxon
Journal:  Thyroid       Date:  1998-09       Impact factor: 6.568

9.  Hypoparathyroidism counteracts risk factors for osteoporosis.

Authors:  J S Touliatos; J I Sebes; A Hinton; D McCommon; J G Karas; G M Palmieri
Journal:  Am J Med Sci       Date:  1995-08       Impact factor: 2.378

10.  Bone mineral density in patients with chronic hypoparathyroidism.

Authors:  S Abugassa; J Nordenström; S Eriksson; G Sjödén
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

View more
  7 in total

Review 1.  Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients.

Authors:  E N Klein Hesselink; T P Links
Journal:  Eur Thyroid J       Date:  2015-06-11

Review 2.  Risk of vertebral fractures in hypoparathyroidism.

Authors:  Anna Maria Formenti; Francesco Tecilazich; Raffaele Giubbini; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 3.  Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

Authors:  Donovan Tay; Serge Cremers; John P Bilezikian
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

Review 4.  Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Rev Endocr Metab Disord       Date:  2020-11-16       Impact factor: 6.514

Review 5.  Bone imaging in hypoparathyroidism.

Authors:  B C Silva; M R Rubin; N E Cusano; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

6.  Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy.

Authors:  Mitsuru Ito; Akira Miyauchi; Mako Hisakado; Waka Yoshioka; Akane Ide; Takumi Kudo; Eijun Nishihara; Minoru Kihara; Yasuhiro Ito; Kaoru Kobayashi; Akihiro Miya; Shuji Fukata; Mitsushige Nishikawa; Hirotoshi Nakamura; Nobuyuki Amino
Journal:  Thyroid       Date:  2017-02-06       Impact factor: 6.568

7.  Site-Specific Difference of Bone Geometry Indices in Hypoparathyroid Patients.

Authors:  Hye Sun Park; Da Hea Seo; Yumie Rhee; Sung Kil Lim
Journal:  Endocrinol Metab (Seoul)       Date:  2017-02-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.